Global Lower GI Series Market Information: By Applications (Gastroenteritis, Colon Polyps, Tumor, Strictures Crohn's Disease, Ulcerative Colitis and others), By Test Types (Double-Contrast and Single-Contrast) and By End Users (Hospitals, Clinics & Laboratories) - Global Forecast till 2023.
Pune, India, MRFR Press Release/- Market Research Future published a research report on “Lower GI Series Market” - Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. The Global Lower GI Series Market is segmented on the basis of by applications, types of tests, and end user.
Moreover, major companies are focusing on investment in R&D to introduce efficient methods as well as innovative devices since they are under constant pressure to provide new and cost-effective methods. The Global Lower GI Series Market is expected to grow at a CAGR of 4.6% during the forecast period 2017-2023 Lower GI series is a lower gastrointestinal series or barium enema; it is one of the medical procedure, which helps in diagnosis of diseases and abnormalities related to human large intestine and rectum.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 60-70 million people are affected by either major or minor GIT diseases in America. The number is continuously increasing due to poor diet and increasing aging population.
The global lower GI series market is driven majorly due to increasing prevalence of GI diseases, gastric cancer, and changing lifestyle. Additionally, developing technologies, increasing cost-effective methods, and the government’s support for research have boosted the growth of this market.
However, availability of alternative therapies may hamper the growth of the market during the review period.
Regional Analysis of the Global Lower GI Series Market:
On the regional basis, the market is segmented into the America, Europe, Asia Pacific, and the Middle East & Africa. The America owns a significant share in the global market as a result of huge investment in research and development in the healthcare sector and its strong economic conditions for research and development.
Europe is the second largest market followed by Asia Pacific on account of increasing technological improvements. The technological improvements will result in higher efficiency and accuracy for diagnosis.
Asia Pacific is the fastest growing market due to increasing prevalence of communicable diseases in this region. India and China have started investing in research and development of healthcare sector, which will boost the market growth of this region.
The Major Key players profiled in the report are Eisai (US), Cadila Pharmaceuticals, PeaceHealth, Purdue Pharma L.P., Alfa Wassermann, NOVADAQ, Mount Sinai Beth Israel, AstraZeneca, and Ironwood Pharmaceuticals Inc.
Report: www.marketresearchfuture.com/check/771 .
Major TOC for Lower GI Series Market:
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
Category: Market Research Publishers and RetailersCompany about: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
For more information: